Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.
Identifieur interne : 003706 ( Ncbi/Merge ); précédent : 003705; suivant : 003707Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.
Auteurs : Pierre Tiberghien [France] ; Xavier De Lambalerie [France] ; Pascal Morel [France] ; Pierre Gallian [France] ; Karine Lacombe [France] ; Yazdan Yazdanpanah [France]Source :
- Vox sanguinis [ 1423-0410 ] ; 2020.
Abstract
Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number CODID-19 cases escalate steeply world-wide. Prior findings in various viral respiratory diseases including SARS-CoV related pneumonia suggest that convalescent plasma can reduce mortality, although formal proof of efficacy is still lacking. By reducing viral spread early on, such an approach may possibly downplay subsequent immunopathology. Identifying, collecting, qualifying and preparing plasma from convalescent patients with adequate SARS-CoV-2 neutralizing Ab titers in an acute crisis setting may be challenging, although well within the remit of most blood establishments. Careful clinical evaluation should allow to quickly establish whether such passive immunotherapy, administered at early phases of the disease in patients at high risk of deleterious evolution may reduce the frequency of patient deterioration, and thereby COVID-19 mortality.
DOI: 10.1111/vox.12926
PubMed: 32240545
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000389
- to stream PubMed, to step Curation: 000389
- to stream PubMed, to step Checkpoint: 000641
Links to Exploration step
pubmed:32240545Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.</title><author><name sortKey="Tiberghien, Pierre" sort="Tiberghien, Pierre" uniqKey="Tiberghien P" first="Pierre" last="Tiberghien">Pierre Tiberghien</name><affiliation wicri:level="1"><nlm:affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Etablissement Français du Sang, La Plaine-St Denis</wicri:regionArea><wicri:noRegion>La Plaine-St Denis</wicri:noRegion><wicri:noRegion>La Plaine-St Denis</wicri:noRegion></affiliation></author><author><name sortKey="De Lambalerie, Xavier" sort="De Lambalerie, Xavier" uniqKey="De Lambalerie X" first="Xavier" last="De Lambalerie">Xavier De Lambalerie</name><affiliation wicri:level="3"><nlm:affiliation>Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Morel, Pascal" sort="Morel, Pascal" uniqKey="Morel P" first="Pascal" last="Morel">Pascal Morel</name><affiliation wicri:level="1"><nlm:affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Etablissement Français du Sang, La Plaine-St Denis</wicri:regionArea><wicri:noRegion>La Plaine-St Denis</wicri:noRegion><wicri:noRegion>La Plaine-St Denis</wicri:noRegion></affiliation></author><author><name sortKey="Gallian, Pierre" sort="Gallian, Pierre" uniqKey="Gallian P" first="Pierre" last="Gallian">Pierre Gallian</name><affiliation wicri:level="1"><nlm:affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Etablissement Français du Sang, La Plaine-St Denis</wicri:regionArea><wicri:noRegion>La Plaine-St Denis</wicri:noRegion><wicri:noRegion>La Plaine-St Denis</wicri:noRegion></affiliation></author><author><name sortKey="Lacombe, Karine" sort="Lacombe, Karine" uniqKey="Lacombe K" first="Karine" last="Lacombe">Karine Lacombe</name><affiliation wicri:level="3"><nlm:affiliation>Sorbonne Université, Inserm IPLESP, Hôpital St Antoine, AP-HP, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sorbonne Université, Inserm IPLESP, Hôpital St Antoine, AP-HP, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Yazdanpanah, Yazdan" sort="Yazdanpanah, Yazdan" uniqKey="Yazdanpanah Y" first="Yazdan" last="Yazdanpanah">Yazdan Yazdanpanah</name><affiliation wicri:level="3"><nlm:affiliation>REACTing Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>REACTing Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32240545</idno><idno type="pmid">32240545</idno><idno type="doi">10.1111/vox.12926</idno><idno type="wicri:Area/PubMed/Corpus">000389</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000389</idno><idno type="wicri:Area/PubMed/Curation">000389</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000389</idno><idno type="wicri:Area/PubMed/Checkpoint">000641</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000641</idno><idno type="wicri:Area/Ncbi/Merge">003706</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.</title><author><name sortKey="Tiberghien, Pierre" sort="Tiberghien, Pierre" uniqKey="Tiberghien P" first="Pierre" last="Tiberghien">Pierre Tiberghien</name><affiliation wicri:level="1"><nlm:affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Etablissement Français du Sang, La Plaine-St Denis</wicri:regionArea><wicri:noRegion>La Plaine-St Denis</wicri:noRegion><wicri:noRegion>La Plaine-St Denis</wicri:noRegion></affiliation></author><author><name sortKey="De Lambalerie, Xavier" sort="De Lambalerie, Xavier" uniqKey="De Lambalerie X" first="Xavier" last="De Lambalerie">Xavier De Lambalerie</name><affiliation wicri:level="3"><nlm:affiliation>Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Morel, Pascal" sort="Morel, Pascal" uniqKey="Morel P" first="Pascal" last="Morel">Pascal Morel</name><affiliation wicri:level="1"><nlm:affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Etablissement Français du Sang, La Plaine-St Denis</wicri:regionArea><wicri:noRegion>La Plaine-St Denis</wicri:noRegion><wicri:noRegion>La Plaine-St Denis</wicri:noRegion></affiliation></author><author><name sortKey="Gallian, Pierre" sort="Gallian, Pierre" uniqKey="Gallian P" first="Pierre" last="Gallian">Pierre Gallian</name><affiliation wicri:level="1"><nlm:affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Etablissement Français du Sang, La Plaine-St Denis</wicri:regionArea><wicri:noRegion>La Plaine-St Denis</wicri:noRegion><wicri:noRegion>La Plaine-St Denis</wicri:noRegion></affiliation></author><author><name sortKey="Lacombe, Karine" sort="Lacombe, Karine" uniqKey="Lacombe K" first="Karine" last="Lacombe">Karine Lacombe</name><affiliation wicri:level="3"><nlm:affiliation>Sorbonne Université, Inserm IPLESP, Hôpital St Antoine, AP-HP, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sorbonne Université, Inserm IPLESP, Hôpital St Antoine, AP-HP, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Yazdanpanah, Yazdan" sort="Yazdanpanah, Yazdan" uniqKey="Yazdanpanah Y" first="Yazdan" last="Yazdanpanah">Yazdan Yazdanpanah</name><affiliation wicri:level="3"><nlm:affiliation>REACTing Inserm, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>REACTing Inserm, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Vox sanguinis</title><idno type="eISSN">1423-0410</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number CODID-19 cases escalate steeply world-wide. Prior findings in various viral respiratory diseases including SARS-CoV related pneumonia suggest that convalescent plasma can reduce mortality, although formal proof of efficacy is still lacking. By reducing viral spread early on, such an approach may possibly downplay subsequent immunopathology. Identifying, collecting, qualifying and preparing plasma from convalescent patients with adequate SARS-CoV-2 neutralizing Ab titers in an acute crisis setting may be challenging, although well within the remit of most blood establishments. Careful clinical evaluation should allow to quickly establish whether such passive immunotherapy, administered at early phases of the disease in patients at high risk of deleterious evolution may reduce the frequency of patient deterioration, and thereby COVID-19 mortality.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32240545</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0410</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Apr</Month><Day>02</Day></PubDate></JournalIssue><Title>Vox sanguinis</Title><ISOAbbreviation>Vox Sang.</ISOAbbreviation></Journal><ArticleTitle>Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/vox.12926</ELocationID><Abstract><AbstractText>Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number CODID-19 cases escalate steeply world-wide. Prior findings in various viral respiratory diseases including SARS-CoV related pneumonia suggest that convalescent plasma can reduce mortality, although formal proof of efficacy is still lacking. By reducing viral spread early on, such an approach may possibly downplay subsequent immunopathology. Identifying, collecting, qualifying and preparing plasma from convalescent patients with adequate SARS-CoV-2 neutralizing Ab titers in an acute crisis setting may be challenging, although well within the remit of most blood establishments. Careful clinical evaluation should allow to quickly establish whether such passive immunotherapy, administered at early phases of the disease in patients at high risk of deleterious evolution may reduce the frequency of patient deterioration, and thereby COVID-19 mortality.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tiberghien</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9310-8322</Identifier><AffiliationInfo><Affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR 1098 RIGHT, Inserm, EFS, Université de Franche-Comté, Besançon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lambalerie</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morel</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallian</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Etablissement Français du Sang, La Plaine-St Denis, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacombe</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sorbonne Université, Inserm IPLESP, Hôpital St Antoine, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdanpanah</LastName><ForeName>Yazdan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>REACTing Inserm, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHP Hôpital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vox Sang</MedlineTA><NlmUniqueID>0413606</NlmUniqueID><ISSNLinking>0042-9007</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">antibody</Keyword><Keyword MajorTopicYN="N">convalescent plasma</Keyword><Keyword MajorTopicYN="N">infectious disease</Keyword><Keyword MajorTopicYN="N">plasma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32240545</ArticleId><ArticleId IdType="doi">10.1111/vox.12926</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Provence-Alpes-Côte d'Azur</li><li>Île-de-France</li></region><settlement><li>Marseille</li><li>Paris</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Tiberghien, Pierre" sort="Tiberghien, Pierre" uniqKey="Tiberghien P" first="Pierre" last="Tiberghien">Pierre Tiberghien</name></noRegion><name sortKey="De Lambalerie, Xavier" sort="De Lambalerie, Xavier" uniqKey="De Lambalerie X" first="Xavier" last="De Lambalerie">Xavier De Lambalerie</name><name sortKey="Gallian, Pierre" sort="Gallian, Pierre" uniqKey="Gallian P" first="Pierre" last="Gallian">Pierre Gallian</name><name sortKey="Lacombe, Karine" sort="Lacombe, Karine" uniqKey="Lacombe K" first="Karine" last="Lacombe">Karine Lacombe</name><name sortKey="Morel, Pascal" sort="Morel, Pascal" uniqKey="Morel P" first="Pascal" last="Morel">Pascal Morel</name><name sortKey="Yazdanpanah, Yazdan" sort="Yazdanpanah, Yazdan" uniqKey="Yazdanpanah Y" first="Yazdan" last="Yazdanpanah">Yazdan Yazdanpanah</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003706 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003706 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:32240545
|texte= Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32240545" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |